2025-05-08
OpenAI is reportedly in discussions with the U.S. Food and Drug Administration (FDA) about using AI to help evaluate pharmaceuticals, according to a new report from Wired.
The article OpenAI plans "cderGPT" for the US Food and Drug Administration (FDA) appeared first on THE DECODER.
[...]2025-02-14
Newly restored pages on the websites of government agencies like the Food and Drug Administration (FDA) and Substance Abuse and Mental Health Services Administration (SAMHSA) now include a disclaimer [...]
2025-03-24
Nothing drives down a drug’s price like competition. According the U.S. Food and Drug Administration (FDA), a drug’s wholesale price drops by an average of 39% after just one generic competitor en [...]
2025-02-12
US District Judge John D. Bates has ordered (PDF) the Center for Disease Control and Food and Drug Administration to restore the web pages and resources they had previously removed to comply with Pres [...]
2025-05-06
OpenAI has abandoned its controversial restructuring plan. In a dramatic reversal, the company said Monday it would no longer try to separate control of its for-profit arm from the non-profit board th [...]
2025-02-03
Nuance Audio, new "hearing glasses" from EssilorLuxottica, have received FDA clearance and "a CE marking under the Medical Devices regulation in the EU," making them officially rea [...]